Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siok Ping Yeo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|November 28, 2012
Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanomaLei Wang, Yu Shi, Peijun Ju, et al.
Cell Research|June 22, 2016
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumabZhenkun Na, Siok Ping Yeo, Sakshibeedu R Bharath, et al.
Mabs|March 28, 2014
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacyAngeline X H Goh, Sebastien Bertin-Maghit, Siok Ping Yeo, et al.
Cancer Research Communications|May 8, 2024
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid TumorsSiok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
Bioconjugate Chemistry|November 11, 2017
Imaging PD-L1 Expression with ImmunoPETCharles Truillet, Hsueh Ling J Oh, Siok Ping Yeo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|November 28, 2012
Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanomaLei Wang, Yu Shi, Peijun Ju, et al.
Cell Research|June 22, 2016
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumabZhenkun Na, Siok Ping Yeo, Sakshibeedu R Bharath, et al.
Mabs|March 28, 2014
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacyAngeline X H Goh, Sebastien Bertin-Maghit, Siok Ping Yeo, et al.
Cancer Research Communications|May 8, 2024
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid TumorsSiok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
Bioconjugate Chemistry|November 11, 2017
Imaging PD-L1 Expression with ImmunoPETCharles Truillet, Hsueh Ling J Oh, Siok Ping Yeo, et al.
Pageof 1